Ischemic Heart Disease clinical trials
21 active trials name this condition. Describe your situation to see which ones you may be eligible for.
By location
- Pulsed Field Ablation for Post-Infarction Ventricular Tachycardia
- Radial Vs. State-Of-The-Art Femoral Access for Bleeding and Access Site Complication Reduction in Cardiac Catheterization (REBIRTH)
- Effect of Dapagliflozin on Microvascular Function in Women With Symptoms of Coronary Artery Disease
- Single or Repeated Intravenous Administration of umbiliCAl Cord Mesenchymal sTrOmal Cells in Ischemic Cardiomyopathy
- Transition to Cardiac Rehabilitation (T2CR) to Address Barriers of Multimorbidity and Frailty
- Using Indoor Air Filtration to Slow Atherothrombosis Progression in Adults With Ischemic Heart Disease History
- Bright Light Exposure in Surgical Patients
- The Multicenter Stress Cardiac Magnetic Resonance Quantitative Perfusion Imaging in the United States Study
- Use of GeriKit to Better Phenotype Older Adults With Ischemic Heart Disease
- Quantitative Cardiac Parametric Mapping
- Safety and Clinical Performance of the Freesolve Resorbable Magnesium Scaffold (RMS) System in Subjects With Coronary Artery Lesions
- A Study Of Deep Learning For Echo Analysis, Tracking, And Evaluation
- DeBakey Cardiovascular Magnetic Resonance Study
- Routine Validation and Reproducibility Testing of Laboratory Assays and Research Techniques Used for Endocrine, Cardiometabolic, and Musculoskeletal Disorder Research (VALD)
- AI-Enabled Direct-from-ECG Ejection Fraction (EF) Severity Assessment Using COR ECG Wearable Monitor
- Development of CIRC Technologies
- HARP Mindfulness Study
- Distal Evaluation of Functional Performance with Intravascular Sensors to Assess the Narrowing Effect: Guided Physiologic Stenting
- Acolyte CTO-PCI Study: Imaging and Catheter System to Treat Patients With Coronary Chronic Total Occlusion, Who Have Persistent Symptoms Following Medical Therapy and Are Undergoing Percutaneous Coronary Interventional Procedures
- Fractional Flow Reserve and Instantaneous Free-wave Ratio Revascularization Strategies in Women
- Ultralow Dose PET Imaging of 18F-flurpiridaz
Guides for people searching for a trial
- Why people get turned down — and what to do nextWhat eligibility criteria are for, what keeps people out, and where to go when the first door closes.
- How your biomarkers decide which trials you qualify forEGFR, HER2, BRAF, PD-L1 and the rest — what they are and why they increasingly gate access.
- How to search for a trial without losing your mindWhere to look, what to gather first, and how to read what you find.
- What Phase 1, 2 and 3 actually mean for youWhat each phase is testing, and how to weigh an early-phase trial against a later one.
- 10 questions to ask before you say yesTreatment, time, cost, safety and your rights. Worth bringing to a screening visit.
- You matched with a trial. What happens now?Phone screens, the screening visit, informed consent, and day one.
Showing active trials that list “Ischemic Heart Disease” as a condition. Eligibility shown on each trial is an estimate — the trial's study team makes the final decision.